GLSI stock is experiencing movement, with some outlets reporting a pre-market surge. The reason for the stock's movement may be related to a development in a breast cancer trial, although the exact cause is unclear. Other stocks, including those of various healthcare and biotechnology companies, are also being reported on, but their connection to GLSI stock is not specified.